Estimating the Future Burden of Cardiovascular Disease in China and the Potential Value of Universal Lipid and Blood Pressure Control

W Stevens; D Peneva; JZ Li; LZ Liu; GG Liu; R Gao; DN Lakdawalla

doi:10.1016/j.jval.2016.03.132

Abstract only| Volume 19, ISSUE 3, PA54, May 01, 2016

Estimating the Future Burden of Cardiovascular Disease in China and the Potential Value of Universal Lipid and Blood Pressure Control

Stevens W
W Stevens
Affiliations
Precision Health Economics, Oakland, CA, USA
Search for articles by this author
Peneva D
D Peneva
Affiliations
Precision Health Economics, Los Angeles, CA, USA
Search for articles by this author
Li JZ
JZ Li
Affiliations
Pfizer, Inc., San Diego, CA, USA
Search for articles by this author
Liu LZ
LZ Liu
Affiliations
Weill Medical College of Cornell University, New York, NY, USA
Search for articles by this author
Liu GG
GG Liu
Affiliations
Peking University, Beijing, China
Search for articles by this author
Gao R
R Gao
Affiliations
Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Search for articles by this author
Lakdawalla DN
DN Lakdawalla
Affiliations
University of Southern California, Los Angeles, CA, USA
Search for articles by this author

Open ArchiveDOI:https://doi.org/10.1016/j.jval.2016.03.132

Cardiovascular disease (CVD) is playing an ever-increasing role in China’s disease burden. This study estimated this burden over the next 15 years and the potential value of universal lipid and blood pressure control strategies.